New York, New York (PRWEB) October 06, 2016
Fit4D, a New York City-based technology company with intelligent scripting algorithms that enable Certified Diabetes Educators (CDEs) to deliver personalized care at scale, announced today that its founder and CEO, David Weingard, will be the keynote speaker at the American Diabetes Association (ADA) “Step Out: Walk to Stop Diabetes” event at the Bronx Zoo on Sunday, October 9th at 9:00am.
David was diagnosed with Type 1 diabetes at the age of 36 while training for a survival race. A veteran of numerous running and triathlons races, David committed to rebuilding his life and providing positive energy to the diabetes community while coping with the condition on a 24×7 basis. David’s personal experience receiving meaningful education and support from a CDE sparked the idea for Fit4D to leverage technology to scale the patient reach of adherence and outcome improvement programs for pharmaceutical, payer and provider organizations.
The “Step Out” event was created to positively impact the lives of those who are affected by diabetes and will bring awareness to the growing New York City diabetes epidemic as it relates largely to at-risk populations. Here are the staggering statistics according to the American Diabetes Association:
- It is estimated that 2 million New Yorkers, or 12.3% of the population now have diabetes.
- Among the population that has diabetes, 517,000 of them simply do not know it.
- 5,412,000 people in New York City, or a staggering 36.2% of the population, have prediabetes.
- Every year an estimated 66,000 people in New York City are diagnosed with diabetes.
- Diabetes disproportionately affects black and Latino New Yorkers, as well as those living in low-income households and neighborhoods.
- Of those diagnosed with diabetes 28% are Latinos/Hispanics and 31% are African Americans.
- In New York City during 2007, 22 African Americans and 23 Latinos/Hispanics of every 100,000 died from diabetes.
- Diabetes prevalence has more than doubled over the past 10 years, according to the city's health department, putting the rates of diabetes among New Yorkers well over those of the nation, which is holding steady at 9.5%.
“I couldn’t be more excited to have been chosen to deliver the keynote speech at such a meaningful event as the “Step Out” Walk to Stop Diabetes event in my hometown of New York City," said David Weingard, founder and CEO of Fit4D. “As a Type 1 diabetes patient and the founder of a company that has made it its mission to improve the lives of people living with diabetes, I am truly honored.”
Fit4D is a technology-enabled health coaching solution that scales the reach of expert diabetes educators, allowing them to manage a patient population more than five times larger than traditional inpatient settings. Fit4D clients include pharmaceutical companies with a branded drug or device seeking to improve initiation and adherence, and payers looking to improve health outcomes and quality measures. The company’s team of CDEs across the country leverage the proprietary technology platform to engage patients with a personalized plan that addresses the individual barriers one faces when learning to self-manage the condition. Coaching topics include basic education about the condition, tips and tactics to initiate therapy and improve medication adherence, the importance of preventive care, nutrition, fitness, advice to overcome psychosocial barriers and more.
Fit4D’s mission is to improve the lives of people living with diabetes worldwide. Fit4D delivers scalable and effective patient programs through an optimized mix of its technology platform and human-based touch points. The Fit4D clinical team of certified diabetes educators (CDEs) is comprised of dietitians, exercise physiologists, nurses, and social workers, who are passionate about empowering people with diabetes to live rich, healthy and fulfilling lives.
Fit4D’s Fortune 500 clients include pharmaceutical, payer, provider and wellness companies. Fit4D has also engaged in numerous joint initiatives with the Juvenile Diabetes Research Foundation, American Diabetes Association, and Diabetes Research Institute.